PipelineNeurocrine’s research and development efforts are focused on neurological and endocrine diseases and disorders. Working as a team, Neurocrine’s R & D and clinical development groups possess the skills and experience to identify, select and optimize new compounds, to screen for therapeutic development, and to advance these compounds efficiently through clinical trials. Their success is the core of Neurocrine’s product pipeline and is fueling our ability to bring multiple novel therapeutics to market. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endorine-related diseases and disorders. 
|
